TE_27540
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | ENSG00000257869 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 409.14 |
| Counts of samples | TCGA_tumor:725; TCGA_normal:1; GTEx:0 |
| TSS | chr14(+):28318140 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_27540.1 | ENSG00000257869 | Chimeric | Non-coding | Non-coding | chr14(+):28318141,28318245,28318415,28318532,28405426,28405472,28418544,28418564 |
| teRNA_27540.2 | ENSG00000257869 | Chimeric | Non-coding | Non-coding | chr14(+):28318141,28318245,28318415,28318591,28405423,28405472,28418544,28418564 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
